N/A
Average AnalystN/A
Top AnalystSlightly Bullish
Stock Target AdvisorN/A
Average UserCHF 36.85
-0.65 (-1.73)%
CHF 2.04B
0.10M
CHF -1.00
Based on the BB Biotech AG stock forecast from 0 analysts, the average analyst target price for BB Biotech AG is not available over the next 12 months. BB Biotech AG’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BB Biotech AG is Slightly Bullish , which is based on 4 positive signals and 2 negative signals. At the last closing, BB Biotech AG’s stock price was CHF 36.85. BB Biotech AG’s stock price has changed by -5.39% over the past week, -5.03% over the past month and -10.99% over the last year.
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company had positive total cash flow in the most recent four quarters.
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The company had negative total free cash flow in the most recent four quarters.